COURTNEY COVERT: Open Payments
NPI 1013464148 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 25 payments from 11 companies in 2025. Trend: 2023 $328 · 2024 $582 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $248 |
| Gilead Sciences, Inc. | 8 | $198 |
| Novo Nordisk Inc | 4 | $72 |
| Abbott Laboratories | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| Becton, Dickinson and Company | 1 | $35 |
| TerSera Therapeutics LLC | 1 | $35 |
| Amgen Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
Products named: Enhertu, FREESTYLE LIBRE 3, Wegovy, Zoladex, EVENITY, AVYCAZ, NUCALA, MOUNJARO.
Industry payments across CO — which companies pay providers there.
